View Cart
Global Information, Inc.
US:
+1-860-674-8796
EU:
+32-2-535-7543
SG:
+65-6223-2436
Home
|
Category
|
Publishers
|
Custom Research
|
E-mail Alert
|
About Us
|
Contact Us
|
Site Map
|
Pharmaceutical
Drug Discovery
Drug Delivery System
Veterinary Medicine
Bone Disease Treatment
Obesity Treatment
Generic Drugs
OTC Drug
Prescription Drugs
Vaccines
Regulation
Cancer
Diabetes
Infection Disease
Mental Disease
Pharmaceutical Companies
Neurodegenerative Disease
View All Categories
Home
>
Category
>
Pharmaceutical
>
Market Research Report
Conducting Clinical Trials in Emerging Markets
Published by
PJB Publications Ltd.
Published
2007/09
Content info
Pages: 201
Product code
PJB58845
Price
From
US $ 4495
US $ 4495
PDF by E-mail (Single User License)
How to Order?
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Table of Contents
ABBREVIATIONS
CHAPTER 1: INTRODUCTION
1.1 Introduction to emerging markets
1.2 Introduction to report structure, tables and sources
CHAPTER 2: INDIA
2.1 General information
2.2 Clinical trials specific information
2.3 Clinical trial activity
2.4 Looking forward
2.5 Summary for India
CHAPTER 3: CHINA
3.1 General information
3.2 Clinical trials specific information
3.3 Clinical trial activity
3.4 Summary for China
CHAPTER 4: SOUTH EAST ASIA
4.1 Hong Kong
4.1.1 General information
4.1.2 Clinical trials specific information
4.2 Republic of (South) Korea
4.2.1 General information
4.2.2 Clinical trials specific information
4.3 Malaysia
4.3.1 General information
4.3.2 Clinical trials specific information
4.4 Philippines
4.4.1 General information
4.4.2 Clinical trials specific information
4.5 Singapore
4.5.1 General information
4.5.2 Clinical trials specific information
4.6 Taiwan
4.6.1 General information
4.6.2 Clinical trials specific information
4.7 Thailand
4.7.1 General information
4.7.2 Clinical trials specific information
4.8 Clinical trial activity: South East Asia
4.9 Summary for region
CHAPTER 5: CENTRAL AND EASTERN EUROPE
5.1 Bulgaria
5.1.1 General information
5.1.2 Clinical trials specific information
5.2 Croatia
5.2.1 General information
5.2.2 Clinical trials specific information
5.3 Czech Republic
5.3.1 General information
5.3.2 Clinical trials specific information
5.4 Estonia
5.4.1 General information
5.4.2 Clinical trials specific information
5.5 Greece
5.5.1 General information
5.5.2 Clinical trials specific information
5.6 Hungary
5.6.1 General information
5.6.2 Clinical trials specific information
5.7 Latvia
5.7.1 General information
5.7.2 Clinical trials specific information
5.8 Lithuania
5.8.1 General information
5.8.2 Clinical trials specific information
5.9 Poland
5.9.1 General information
5.9.2 Clinical trials specific information
5.10 Romania
5.10.1 General information
5.10.2 Clinical trials specific information
5.11 Russia
5.11.1 General information
5.11.2 Clinical trials specific information
5.12 Serbia
5.12.1 General information
5.12.2 Clinical trials specific information
5.13 Slovak Republic
5.13.1 General information
5.13.2 Clinical trials specific information
5.14 Slovenia
5.14.1 General information
5.14.2 Clinical trials specific information
5.15 Turkey
5.15.1 General information
5.15.2 Clinical trials specific information
5.16 Ukraine
5.16.1 General information
5.16.2 Clinical trials specific information
5.17 Clinical trial activity: CEE countries
5.18 Summary for region
CHAPTER 6: LATIN AMERICA
6.1 Argentina
6.1.1 General information
6.1.2 Clinical trials specific information
6.2 Brazil
6.2.1 General information
6.2.2 Clinical trials specific information
6.3 Chile
6.3.1 General information
6.3.2 Clinical trials specific information
6.4 Colombia
6.4.1 General information
6.4.2 Clinical trials specific information
6.5 Costa Rica
6.5.1 General information
6.5.2 Clinical trials specific information
6.6 Mexico
6.6.1 General information
6.6.2 Clinical trials specific information
6.7 Panama
6.7.1 General information
6.7.2 Clinical trials specific information
6.8 Peru
6.8.1 General information
6.8.2 Clinical trials specific information
6.9 Puerto Rico
6.9.1 General information
6.9.2 Clinical trials specific information
6.10 Uruguay
6.10.1 General information
6.10.2 Clinical trials specific information
6.11 Venezuela
6.11.1 General information
6.11.2 Clinical trials specific information
6.12 Clinical trials activity: Latin America
6.13 Summary for region
CHAPTER 7: MIDDLE EAST
7.1 Israel
7.1.1 General information
7.1.2 Clinical trials specific information
7.2 Clinical trial activity: Middle East
7.3 Summary for region
CHAPTER 8: AFRICA
8.1 Egypt
8.1.1 General information
8.1.2 Clinical trials specific information
8.2 South Africa
8.2.1 General information
8.2.2 Clinical trials specific information
8.3 Uganda
8.3.1 General informationclvi
8.3.2 Clinical trials specific information
8.4 Clinical trial activity: Africa
8.5 Summary for region
CHAPTER 9: DISCUSSION AND SUMMARY
ANNEX I
REFERENCES
LIST OF TABLES
Table 1.1: List of countries considered for inclusion in this report
Table 2.1: India: Country population statistics
Table 2.2: Number of government allopathic hospitals and hospital beds in rural and urban areas (including CHCs)vii
Table 2.3: Total government allopathic hospitals (including CHCs) and beds and ratio to populationviii
Table 2.4: India: Country healthcare statistics
Table 2.5: Regulatory agency and other websites for India
Table 2.6: Requirements for filing applications for global clinical trials
Table 2.7: India: US FDA audit results
Table 2.8: Indian population groups
Table 2.9: Top ten commercial sponsors of clinical trials in India
Table 2.10: Top ten disease areas subject to clinical trials in India
Table 3.1: Regulatory agency and other websites for China
Table 3.2: China: US FDA audit results
Table 3.3: Top ten commercial sponsors of clinical trials in China
Table 3.4: Top ten disease areas being studied in China
Table 4.1: SE Asia: Country population statistics
Table 4.2: SE Asia: Country healthcare statistics
Table 4.3: SE Asia: US FDA audit results
Table 4.4: Regulatory agency and other websites for Hong Kong
Table 4.5: South Korea: Country population statistics
Table 4.6: South Korea: Country healthcare statistics
Table 4.7: Regulatory agency and other websites for South Korea
Table 4.8: Malaysia: Country population statistics
Table 4.9: Malaysia: Country healthcare statistics
Table 4.10: Regulatory agency and other websites for Malaysia
Table 4.11: Philippines: Country population statistics
Table 4.12: Philippines: Country healthcare statistics
Table 4.13: Regulatory agency and other websites for Philippines
Table 4.14: Singapore: Country population statistics
Table 4.15: Singapore: Country healthcare statistics
Table 4.16: Regulatory agency and other websites for Singapore
Table 4.17: Taiwan: Country population statistics
Table 4.18: Regulatory agency and other websites for Taiwan
Table 4.19: Thailand: Country population statistics
Table 4.20: Thailand: Country healthcare statistics
Table 4.21: Regulatory agency and other websites for Thailand
Table 4.22: Top ten commercial sponsors of clinical trials in SE Asia
Table 4.23: Top ten diseases subject to clinical trials in SE Asia
Table 4.24: Top ten diseases subject to clinical trials in Hong Kong
Table 4.25: Total study numbers and US FDA audit results for SE Asia
Table 4.26: Population and study numbers Selected countries
Table 5.1: CEE: Country population statistics
Table 5.2: CEE: Country healthcare statistics
Table 5.3: Top eight countries in CEE for clinical trials according to ClinicalTrials.gov
Table 5.4: CEE: US FDA audit results
Table 5.5: Bulgaria: Country population statistics
Table 5.6: Bulgaria: Country healthcare statistics
Table 5.7: Regulatory agency and other websites for Bulgaria
Table 5.8: Croatia: Country population statistics
Table 5.9: Croatia: Country healthcare statistics
Table 5.10: Regulatory agency and other websites for Croatia
Table 5.11: Czech Republic: Country population statistics
Table 5.12: Czech Republic: Country healthcare statistics
Table 5.13: Regulatory Agency and other Websites for the Czech Republic
Table 5.14: Estonia: Country population statistics
Table 5.15: Estonia: Country healthcare statistics
Table 5.16: Regulatory agency and other websites for Estonia
Table 5.17: Greece: Country population statistics
Table 5.18: Greece: Country healthcare statistics
Table 5.19: Regulatory agency and other websites for Greece
Table 5.20: Hungary: Country population statistics
Table 5.21: Hungary: Country healthcare statistics
Table 5.22: Regulatory agency and other websites for Hungary
Table 5.23: Latvia: Country population statistics
Table 5.24: Latvia: Country healthcare statistics
Table 5.25: Regulatory agency and other websites for Latvia
Table 5.26: Lithuania: Country population statistics
Table 5.27: Lithuania: Country healthcare statistics
Table 5.28: Regulatory agency and other websites for Lithuania
Table 5.29: Poland: Country population statistics
Table 5.30: Poland: Country healthcare statistics
Table 5.31: Regulatory agency and other websites for Poland
Table 5.32: Romania: Country population statistics
Table 5.33: Romania: Country healthcare statistics
Table 5.34: Regulatory agency and other websites for Romania
Table 5.35: Russia: Country population statistics
Table 5.36: Russia: Country healthcare statistics
Table 5.37: Regulatory agency and other websites for Russia
Table 5.38: Serbia: Country population statistics
Table 5.39: Serbia: Country healthcare statistics
Table 5.40: Regulatory agency and other websites for Serbia
Table 5.41: Slovakia: Country population statistics
Table 5.42: Slovakia: Country healthcare statistics
Table 5.43: Regulatory agency and other websites for Slovakia
Table 5.44: Slovenia: Country population statistics
Table 5.45: Slovenia: Country healthcare statistics
Table 5.46: Regulatory agency and other websites for Slovenia
Table 5.47: Slovenia: US FDA audit results
Table 5.48: Turkey: Country population statistics
Table 5.49: Turkey: Country healthcare statistics
Table 5.50: Regulatory agency and other websites for Turkey
Table 5.51: Ukraine: Country population statistics
Table 5.52: Ukraine: Country healthcare statistics
Table 5.53: Regulatory Agency and other websites for Ukraine
Table 5.54: Top ten commercial sponsors of clinical trials in CEE
Table 5.55: Top ten diseases subject to clinical trials in CEE
Table 6.1: Latin America: Country population statistics
Table 6.2: Latin America: Country healthcare statistics
Table 6.3: Agencies for region Latin America
Table 6.4: Argentina: Country population statistics
Table 6.5: Argentina: Country healthcare statistics
Table 6.6: Regulatory agency and other websites for Argentina
Table 6.7: Brazil: Country population statistics
Table 6.8: Capacity of the Brazilian health sector, 1992
Table 6.9: Brazil: Country healthcare statistics
Table 6.10: Regulatory agency and other websites for Brazil
Table 6.11: Chile: Country population statistics
Table 6.12: Chile: Country healthcare statistics
Table 6.13: Regulatory agency and other websites for Chile
Table 6.14: Latin America: Country healthcare statistics
Table 6.15: Regulatory agency and other websites for Columbia
Table 6.16: Costa Rica: Country population statistics
Table 6.17: Costa Rica: Country healthcare statistics
Table 6.18: Regulatory agency and other websites for Costa Rica
Table 6.19: Mexico: Country population statistics
Table 6.20: Mexico: Country healthcare statistics
Table 6.21: Regulatory agency and other websites for Mexico
Table 6.22: Panama: Country population statistics
Table 6.23: Panama: Country healthcare statistics
Table 6.24: Regulatory agency and other websites for Panama
Table 6.25: Peru: Country population statistics
Table 6.26: Peru: Country healthcare statistics
Table 6.27: Regulatory agency and other websites for Peru
Table 6.28: Puerto Rico: Country population Statistics
Table 6.29: Regulatory agency and other websites for Puerto Rico
Table 6.30: Uruguay: Country population statistics
Table 6.31: Uruguay: Country healthcare statistics
Table 6.32: Regulatory agency and other websites for Uruguay
Table 6.33: Venezuela: Country population statistics
Table 6.34: Venezuela: Country healthcare statistics
Table 6.35: Regulatory agency and other websites for Venezuela
Table 6.36: Top ten commercial sponsors of clinical trials in Latin America
Table 6.37: Top ten disease areas subject to clinical trials in Latin America
Table 6.38: Total study numbers and US FDA audit results for Latin America
Table 6.39: Countries with US FDA audit results showing official action indicated (OAI)
Table 6.40: Top 20 countries (in this report) for ClinicalTrials.gov
Table 7.1: Middle East: Country population statistics
Table 7.2: Middle East: Country healthcare statistics
Table 7.3: Middle East US FDA audit results
Table 7.4: Israel: Country population statistics
Table 7.5: Israel: Country healthcare statistics
Table 7.6: Israel' s healthcare infrastructure 2002
Table 7.7: Regulatory agency and other websites for Israel
Table 7.8: Top ten commercial sponsors of clinical trials in Israel
Table 7.9: Top ten disease areas subject to clinical trials in Israel
Table 7.10: Top clinical trials destinations for this report, plus selected other countries, per ClinicalTrials.gov
Table 7.11: Israel compared with selected other Middle Eastern countries
Table 8.1: Africa: Country population statistics
Table 8.2: Africa: Country healthcare statistics
Table 8.3: Africa: US FDA audit results
Table 8.4: Egypt: Country population statistics
Table 8.5: Egypt: Country healthcare statistics
Table 8.6: Regulatory agency and other websites for Egypt
Table 8.7: South Africa: Country population statistics
Table 8.8: South Africa: Country healthcare statistics
Table 8.9: Regulatory agency and other websites for South Africa
Table 8.10: Uganda: Country population statistics
Table 8.11: Uganda: Country healthcare statistics
Table 8.12: Regulatory agency and other websites for Uganda
Table 8.13: Top ten pharmaceutical company sponsors of clinical trials in South Africa
Table 8.14: Top ten disease areas subject to clinical trials in South Africa
Table 9.1: Top countries participating in new FDA-regulated trials in 2006
Table 9.2: Labour costs for selected emerging countries1
Table 9.3: Sponsors of clinical trials in India
Table 9.4: Disease areas being studied in Indian trials
Table 9.5: Sponsors of ongoing clinical trials in China
Table 9.6: Disease areas being studied in China
LIST OF FIGURES
Figure 3.1: SFDA organisation chart, abridgedxxvii
Figure 3.2: Application and approval procedure for clinical trials xxxiii
Related Report
The 111th U.S. Congress Tackles Healthcare Reform and the Pharmaceutical Industry
The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
Algeria Pharmaceuticals and Healthcare Report Q4 2009
Argentina Pharmaceuticals and Healthcare Report Q4 2009
Australia Pharmaceuticals and Healthcare Report Q4 2009
Please inform me when related publications are released
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.
View Cart
